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Abstract
Issues. Indigenous peoples of Australia, New Zealand, Canada and the United States experience a disproportionately high burden
of harms from substance misuse. Research is therefore required to improve our understanding of substance use in Indigenous popu-
lations and provide evidence on strategies effective for reducing harmful use. Approach. A search of 13 electronic databases for
peer-reviewed articles published between 1993 and 2014 focusing on substance use and Indigenous peoples of Australia, New
Zealand, Canada and the United States. Relevant abstracts were classiﬁed as data or non-data based research. Data-based studies
were further classiﬁed as measurement, descriptive or intervention and their trends examined by country and drug type. Intervention
studies were classiﬁed by type and their evaluation designs classiﬁed using the Cochrane Effective Practice and Organisation of Care
(EPOC) data collection checklist.KeyFindings.There was a statistically signiﬁcant increase from 1993 to 2014 in the percentage
of total publications that were data-based (P < 0.001). Overall, data-based publications were mostly descriptive for all countries
(84–93%) and drug types (74–95%). There were fewer measurement (0–4%) and intervention (0–14%) publications for all
countries and the percentage of these did not change signiﬁcantly over time. Forty-two percent of intervention studies employed an
EPOC evaluation design. Implications. Strategies to increase the frequency and quality of measurement and intervention research
in the Indigenous drug and alcohol ﬁeld are required. Conclusion. The dominance of descriptive research in the Indigenous drug
and alcohol ﬁeld is less than optimal for generating evidence to inform Indigenous drug and alcohol policy and programs. [Clifford
A, Shakeshaft A. A bibliometric review of drug and alcohol research focused on Indigenous peoples of Australia, New
Zealand, Canada and the United States. Drug Alcohol Rev 2017;00:000-000]
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Introduction
Indigenous peoples of Australia, New Zealand, Canada
and the United States experience a disproportionately
high burden of drug and alcohol-related mortality [1–5].
Drug- and alcohol-related morbidity is also dispropor-
tionately higher among Indigenous peoples from these
countries, including for example, foetal alcohol spectrum
disorder [6,7], alcoholic cirrhosis [8,9], alcohol-related
injury [10,11], tobacco-related cancers [3,12] andmental
disorders [3,11].
In addition to improving knowledge about the causes,
levels and patterns of drug and alcohol use in Indigenous
populations, research can also provide evidence about
which intervention strategies are most cost-effective for
reducing the deleterious health, social and psychological
effects of drugs and alcohol on Indigenous peoples [13].
The extent to which research contributes to both describ-
ing harms and evaluating interventions aimed at reducing
them will depend on research output in the Indigenous
drug and alcohol ﬁeld.
Examining the number and type of research publica-
tions in a speciﬁc area can provide a broad indication of
research output [14]. The number of research publica-
tions that are data based, relative to those that are not,
for example, can establish the amount of primary data
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available to contribute to the evidence. Moreover, the
types of data-based studies (e.g. measurement, descrip-
tive and intervention) published provide an indication
of the type of evidence available. Examining the number
of these types of publications in the Indigenous drug
and alcohol research ﬁeld would provide an indication
as to the extent to which research has progressed fromde-
scribing drug and alcohol issues in Indigenous popula-
tions, to establishing evidence of the effectiveness of
intervention strategies designed to reduce drug and
alcohol-related harms in Indigenous communities.
Study design is an indicator commonly used to assess
the extent to which research evaluating the effectiveness
of an intervention contributes to strengthening the evi-
dence base [15]. Identifying the type of study designs
used to evaluate drug and alcohol interventions targeting
Indigenous peoples can provide an indication as to the
strength of the Indigenous drug and alcohol evidence
base [16]. It can also identify key gaps and areas for im-
provement. Such information may assist research and
government funding agencies to identify priority study
designs to strengthen the Indigenous drug and alcohol
evidence base which, in turn, provides policy makers
and health services with more reliable and valid evidence
to inform drug and alcohol policies and programs
targeting Indigenous peoples.
The overall aim of this review is to analyse the output of
peer-reviewed drug and alcohol publications focused on
Indigenous peoples of Australia, Canada, New Zealand
and the United States for the period 1993–2014. Speciﬁ-
cally, this review aims to: ﬁrst, identify the number of
drug and alcohol peer-reviewed publications focused on
Indigenous peoples of Australia, New Zealand, Canada
and the United States and the percentage of these that
are data based; second, classify data-based studies as de-
scriptive, measures or intervention research to determine
the trend in these types of publications over time; and
third, identify the foci, outcome measures and study
design of intervention studies to determine the nature
and quality of evidence available to inform Indigenous
drug and alcohol policy and programs.
Methods
Search strategy
Figure 1 summarises the databases searched, the search
terms used, the exclusion criteria and classiﬁcation of
studies.
The search strategy was consistent with methods
detailed in the Cochrane Collaboration Handbook on
Systematic Reviews of Health Promotion and Public
Health Interventions [15]. A qualiﬁed archivist identiﬁed
13 relevant electronic databases to search:
APAIS-ATSIS, ATSIHealth, Campbell Library,
CINAHL, Cochrane Database of Systematic Reviews,
DRUG, Embase, Global Health, Medline, NDARC
Library, Project Cork, PsycINFO and PubMed. Elec-
tronic databases were searched individually with speciﬁc
search strings as this search method is more effective at
identifying relevant articles than a simultaneous search
using generic search terms. An initial search of databases
was conducted in October 2013 for the time period
1993–2013 (16 October). Given evidence of the small
number of peer reviewed studies in the Indigenous health
ﬁeld [14], a 20 year time period was selected to obtain
sufﬁcient numbers of different types of studies to quantify
changes in published Indigenous drug and alcohol
research over time. The initial search identiﬁed 2421
references (after electronic removal of 1169 duplicate ref-
erences). An updated search was conducted in July 2015
for the period 2013 to 2014, to extend the time period to
December 2014. The 22 year period was selected to
allow enough time for completion of the research and
publication of the ﬁndings, balanced against limiting
recall bias about studies completed too long ago. This
updated search identiﬁed an additional 266 references
(after electronic removal of duplicates). Combined, the
initial and updated search identiﬁed 2687
citations/abstracts that were imported into Endnote.
Classiﬁcation of studies
The abstracts of the 2687 identiﬁed references were
examined and classiﬁed in a three-step process.
Step 1: Identiﬁcation of studies for exclusion. Papers were
excluded if: (i) Indigenous peoples of Australia, New
Zealand, Canada or the USA were not the main study
population (n = 601); (ii) alcohol or drugs was not the
focus of the study (n = 568); (iii) they were not a journal
article (n = 337); or (iv) they were a duplicate (n = 135).
Step 1 excluded 1641 publications, leaving 1046 remain-
ing studies.
Step 2: Classiﬁcation of studies. The remaining studies
(n = 1046) were classiﬁed by research type using
criteria derived and adapted from previous reviews
[14]. Studies were initially classiﬁed into Data-based
(n = 656), deﬁned as original articles reporting new
data or analysis of existing data, or Non-data based
(n = 390), deﬁned as research-reports of study
protocols, commentaries, opinion articles, case studies
or summaries of previous research (i.e. reviews).
Data-based studies were further categorised using a
classiﬁcation system employed in previous reviews
[17–20]:Measurement, deﬁned as studies concerned pri-
marily with developing drug or alcohol measurement
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instruments and/or testing their psychometric properties
(n = 19); Descriptive, deﬁned as quantitative or qualita-
tive research exploring the frequency, patterns, or
predictors of smoking, alcohol, or other drug use, or
related variables, such as knowledge, attitudes, harms,
perceptions or experiences. (n = 564); and Intervention,
deﬁned as evaluations or trials of interventions (e.g.
programs, services or policies) designed to reduce drug
or alcohol use and/or related harm, evaluations or trials
of intervention approaches that included alcohol or
other drugs as an outcome predictor variable, or evalu-
ations of approaches for improving the uptake of drug
or alcohol interventions by healthcare practitioners
(n = 73). If a publication focused on both descriptive
and intervention issues, it was classiﬁed as intervention
research. If it focused on both measurement and
descriptive issues, it was classiﬁed as measurement
research.
A randomly selected sample of 100 articles (~20%)
classiﬁed in step two were re-classiﬁed by a blinded
research assistant to cross-check classiﬁcations
performed by the ﬁrst author. Agreement between coders
was good (kappa = 0.62). Discrepancies were discussed
and resolved. Because of sufﬁcient agreement between
Figure 1. Flowchart indicating search strategy and classiﬁcation of studies.
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coders cross-checking more than 20% of classiﬁcations
was deemed unnecessary.
Step 3: Classiﬁcation of intervention studies. The abstracts
of the 73 intervention studies were further classiﬁed using
a modiﬁed version of a taxonomy for classifying drug and
alcohol interventions [21]. The original taxonomy was
rated highly in a review of schemes for classifying drug
policy interventions [22] and includes four categories:
law enforcement, prevention, treatment and harm reduc-
tion [23]. In applying the taxonomy to classify drug and
alcohol interventions identiﬁed in this review, two modi-
ﬁcations were made: ﬁrst, the category law enforcement
was replaced with supply reduction and included the
subcategories of law enforcement and regulation, to
distinguish between supply reduction strategies that use
law enforcement and those that do not; and second, a
ﬁfth category, dissemination, was included to determine
the extent to which strategies designed to integrate
evidence distilled from drug and alcohol research into
practice are being evaluated in Indigenous communities
[24]. The ﬁve categories deﬁned included: (i) Supply
Reduction, deﬁned as either ‘law enforcement’—laws
targeting individuals or sub-groups of drinkers that
normally require police enforcement to be effective, such
as alcohol free zones/bans on public drinking; or ‘regula-
tion’—laws that do not normally require active law
enforcement, such as trading hours and bans on some
types of alcohol sales; (ii) Prevention, deﬁned as strategies
to prevent or delay the onset or development of substance
misuse problems or harms in individuals at risk; (iii)
Treatment, deﬁned as strategies designed to treat individ-
uals with or at risk of drug or alcohol dependence; (iv)
Harm reduction, deﬁned as strategies designed to reduce
harms from substance misuse in individuals and the
community; and (v)Dissemination, deﬁned as interventions
designed to improve delivery of drug and alcohol
interventions to Indigenous peoples.
Broad characteristics of intervention studies in each of
the ﬁve categories were summarised using criteria related
to the drug targeted, intervention type and setting, study
design and outcomes measured. Cochrane’s Effective
Practice and Organisation of Care (EPOC) data collec-
tion checklist was used to classify intervention studies
by their evaluation design [16]: randomised controlled
trial (RCT), controlled clinical trial, controlled before
and after study and interrupted time series. The checklist
was chosen because it includes criteria to facilitate inclu-
sion of non-experimental evaluation designs (i.e. those
without randomisation or a control group). Evaluation
designs not meeting EPOC criteria were classiﬁed as
Non-EPOC.
Statistical analysis
All analyses were performed using STATA Version
13. Tests for signiﬁcant differences in the overall
distribution of studies used the χ2 statistic, reporting
degrees of freedom (df) and the probability value
(P). Fischer’s exact test was used if any value in any
cell was <5 [25].
Results
Number of publications and percentage that were data based
Figure 2 shows the number of data and non-data based
drug and alcohol publications focused on Indigenous
Figure 2. Number of data and non-data based publications, 1993–2014.
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peoples of Australia, New Zealand, Canada and the
United States for each year from 1993 to 2014. There
was a statistically signiﬁcant increase over time in the per-
centage of publications that were data-based
(X2 = 60.2892 df = 21 P < 0.0001).
Type of data-based publications
The number of data-based publications classiﬁed as
measurement and intervention for each year from 1993
to 2014 was typically small (<5). The years from 1993
to 2014 were therefore grouped into three time periods:
1993–2000; 2001–2007 and 2008–2014. Measurement
and descriptive categories were collapsed, and χ² or
Fischer exact tests of publication type (intervention/
other) by time were undertaken.
Table 1 shows the number and percentage of
data-based publications classiﬁed into measurement,
descriptive and intervention subcategories for each
country in each time period.
Overall, data-based publications were predominately
descriptive (564 of the 656 publications), comprising
84% (n = 72) of publications in 1993–2000, 84%
(n = 144) in 2001–2007, and 87% (n = 346) in
2008–2014. Intervention studies (73 of the 656
publications), comprised 16% (n = 14) of publications
in 1993–2000, 11% in 2001–2007 (n = 19) and 10% in
2008–2014 (n = 40). Measurement studies (19 of the
656 publications) comprised 0% in 1993–2000, 5%
(n = 9) in 2001–2007, and 3% (n = 10) in 2008–2014.
The distribution of studies had not changed signiﬁcantly
across time periods (X2 = 1.6593 df = 2 P = 0.436). The
distribution did not change signiﬁcantly over time for any
country (P > 0.05).
Table 2 shows the number and percentage ofmeasure-
ment, descriptive and intervention studies for alcohol,
tobacco, illicit and poly-drug use in each time period.
Tobacco and alcohol were the focus of 40% (n = 263)
and 27% (n = 176) of data-based studies, respectively.
Poly drug use was the focus of 19% of studies
(n = 127), with alcohol (n = 78), cannabis (n = 62) and
tobacco (n = 50) the three most common drugs targeted.
Fourteen percent of studies targeted an illicit drug, most
commonly cannabis, and 2% targeted inhalants. The
distribution of studies over time periods did not change
signiﬁcantly for alcohol (P = 0.07), tobacco (P = 0.27),
illicit (P = 0.74) or poly drug use (P = 0.69) publications.
The change in the distribution of solvent publications
could not be determined because of their zero number
of intervention studies.
Table 1. Number and percentage of data-based studies classiﬁed as measurement, descriptive or intervention research by country
Totals Measurement, n (%) Descriptive, n (%) Intervention, n (%)
United States
1993–2000 40 0 (0%) 35 (87%) 5 (13%)
2001–2007 73 4 (5%) 64 (88%) 5 (7%)
2008–2014 163 2 (1%) 148 (91%) 13 (8%)
Totals 276 6 (2%) 246 (89%) 23 (8%)
Australia
1993–2000 36 0 (0%) 29 (81%) 7 (19%)
2001–2007 55 5 (9%) 39 (71%) 11 (20%)
2008–2014 134 7 (6%) 109 (81%) 18 (13%)
Totals 225 12 (5%) 177 (79%) 36 (16%)
New Zealand
1993–2000 4 0 (0%) 3 (75%) 1 (25%)
2001–2007 24 0 (0%) 21 (88%) 3 (12%)
2008–2014 41 1 (3%) 36 (87%) 4(10%)
Totals 69 1 (1%) 60 (87%) 8 (12%)
Canada
1993–2000 6 0 (0%) 5 (83%) 1 (17%)
2001–2007 20 0 (0%) 20 (100%) 0 (0%)
2008–2014 59 0 (0%) 55 (93) 5 (7%)
Totals 86 0(0%) 80 (93%) 6 (7%)
Total
1993–2014 656 19 (3%) 564 (86%) 73 (11%)
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Broad characteristics of intervention studies
Table 3 summarises the characteristics of intervention
studies. Of the 73 intervention studies, 25 were classiﬁed
as Prevention, 22 Treatment, 11 Supply Reduction, 7
Harm Reduction and 8 Dissemination.
Prevention interventions primarily evaluated
education (n= 10 studies) andmassmedia (n= 6 studies)
strategies targeting tobacco or alcohol. Drug use was a
primary outcome measure for 20 out of 25 prevention
interventions.
Thirteen out of 22 treatment interventions evaluated
pharmacotherapies, alone or in combination with a
behavioural intervention (i.e. counselling). Tobacco
(n = 10 studies) was the drug most commonly targeted
by treatment interventions. Drug use was a primary out-
come measure for 20 out of 22 treatment interventions,
followed by drug-related harms (n = 7 studies).
Ten out of 11 supply reduction interventions evaluated
community level alcohol restrictions. Alcohol-related
harms were a primary outcome measure for almost
two-thirds of these types of interventions (n = 7 studies),
followed by alcohol use (n = 4 studies).
Four out of seven harm reduction interventions evalu-
ated multiple strategies targeting alcohol, three of which
identiﬁed alcohol use as the primary outcome measure.
Dissemination interventions evaluated strategies to
improve the uptake of alcohol and/or tobacco interven-
tions in primary health care or community settings.
Study designs employed by intervention studies
Table 4 summarises the number and percentage of
intervention studies employing EPOC and non-EPOC
evaluation designs.
Of the 73 intervention studies, 41% (n = 30) employed
an EPOC (13 controlled before and after; 10 randomised
controlled trials and 7 interrupted time series) and 59%
(n = 43) a non-EPOC (30 single before and after; 10
post-test; and 1 each of case study, cross-sectional and
longitudinal cohort) evaluation design. The percentage
Table 2. Number and percentage of data-based studies classiﬁed as measurement, descriptive or intervention research by drug type
Totals Measurement, n (%) Descriptive, n (%) Intervention, n (%)
Alcohol
1993–2000 34 0 (0%) 25 (74%) 9 (26%)
2001–2007 47 2 (4%) 41(87%) 4 (9%)
2008–2014 95 2 (4%) 81 (82%) 12 (15%)
Totals 176 4 (2%) 147 (84%) 25 (14%)
Tobacco
1993–2000 20 0 (0%) 17 (85%) 3 (15%)
2001–2007 63 2 (3%) 51(81%) 10(16%)
2008–2014 180 4 (2%) 160 (88%) 16 (9%)
Totals 263 6 (2%) 228 (87%) 29 (11%)
Illicits -
1993–2000 6 0 (0%) 5 (83%) 1 (17%)
2001–2007 30 3 (10%) 24 (80%) 3 (10%)
2008–2014 43 1 (2%) 39 (91%) 3 (7%)
Totals 79 4 (4%) 68 (88%) 7 (8%)
Inhalants
1993–2000 4 0 (0%) 4 (100%) 0 (0%)
2001–2007 4 0 (0%) 4 (100%) 0 (0%)
2008–2014 3 0 (0%) 3 (100%) 0 (0%)
Totals 11 0 (0%) 11 (100%) 0 (0%)
Poly-drug use
1993–2000 22 0 (0%) 21 (95%) 1 (5%)
2001–2007 28 2 (4%) 24 (89%) 2 (7%)
2008–2014 77 3 (5%) 65 (83%) 9 (14%)
Totals 127 5 (4%) 110 (87%) 12 (9%)
Total
1993–2014 656 19 (3%) 564 (86%) 73 (11%)
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of interventions evaluated using an EPOC design was
highest from 1993 to 2000 (50%) and lowest from 2001
to 2007 (26%). The percentage of interventions evalu-
ated using an EPOC design did not change signiﬁcantly
over time (X2 = 2.7211 df = 2 P = 0.257).
Discussion
This review examined broad patterns of Indigenous drug
and alcohol research output over the past 20 years.
Encouragingly, the proportion of publications that were
data based increased steadily over the time period. Less
encouraging, 86% of all data-based publications were de-
scriptive studies, with only 11% assessing the effective-
ness of interventions. This predominance of descriptive
studies was consistent for all time periods, countries
and types of drugs. This ﬁnding is consistent with that
of previous reviews examining research output in the
drug and alcohol [20,26,27] and Indigenous health
[14,28] ﬁelds. This indicates that, as with drug and
alcohol and Indigenous health research generally, the
development of intervention research in the Indigenous
drug and alcohol ﬁeld is progressing slowly, limiting the
amount and quality of evidence available to inform
policies and programs implemented to reduce drug and
alcohol harms in Indigenous communities.
Compounding this is the small number of dissemination
studies, which, consistent with previous research
[24,29,30], suggests that the implementation of evidence
distilled from drug and alcohol research in Indigenous
communities is not being rigorously evaluated and the re-
sults consistently published in the peer review literature.
Measurement articles constituted 0–9% of research
publications for all time periods, countries and drug
types. This is less than optimal, considering that valid
and reliable measurement tools are required for rigorous
descriptive and intervention research. Tobacco and alco-
hol publications had a lower percentage of measurement
studies than illicit and poly-drug use publications. Given
that tobacco and alcohol accounted for 40% and 27% of
data-based publications, respectively, it might have been
expected that a larger percentage of research outputs in
these ﬁelds would have been allocated to developing
and testingmeasurement tools. If the validity and reliabil-
ity of tobacco and alcohol measures are not rigorously
established for Indigenous peoples, the accuracy of prev-
alence data examining patterns of use, outcome data
assessing the effect of interventions designed to reduce
use and screening instruments to detect individuals with
at risk use are likely to be questionable. For example, in
their critique of a national survey of Indigenous alcohol
use in Australia, Chikritzhs and Brady found that less
than optimal measures contributed to an underestima-
tion of Indigenous alcohol use [31]. They concluded that
an understanding of Indigenous cultures and drinking
patterns are required to obtain reliable and accurate
measures of Indigenous alcohol use. Encouragingly,
there is some evidence from the relatively small number
of drug and alcohol measurement studies conducted in
Indigenous communities of researchers working with
Indigenous communities to develop reliable and accurate
measures of Indigenous drug and alcohol use that are
culturally appropriate and acceptable to Indigenous
peoples [32–36].
Intervention studies
The variations in the number and types of interventions
evaluated may reﬂect differences in prevalence and
harms, and levels of funding and political support for
alcohol, tobacco and illicit drugs. The dominance of
alcohol and tobacco intervention evaluations is consistent
with Indigenous peoples experiencing a higher burden of
harm from alcohol and tobacco than other drugs [3,5].
Similarly, the higher percentage of treatment interven-
tions for smoking is consistent with tobacco smoking
being a leading behavioural risk factor of death and
disease in Indigenous populations [37]. Although the
percentage of research that is intervention is highest for
tobacco, it is concerning that the percentage of tobacco
intervention research has remained low from
1993–2000 (15%) to 2008–2014 (9%). This low
Table 4. Number (%) of intervention studies and respective EPOC evaluation designs in each time period
Time period EPOC Non-EPOC Total
RCT CBA ITS
1993–2000 1 (8%) 3 (29%) 3 (29%) 7 (50%) 14
2001–2007 1 (5%) 3 (16%) 1 (5%) 14 (74%) 19
2008–2014 8 (20%) 7 (17%) 4 (10%) 21 (53%) 40
Total 10 (13%) 13 (18%) 7 (10%) 43 (59%) 73
CBA, controlled before and after study; EPOC, Cochrane Effective Practice and Organisation of Care; ITS, interrupted time series;
RCT, randomised controlled trial.
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proportion of tobacco intervention research is a particular
problem for Indigenous peoples because they are
over-represented in low-socioeconomic status
sub-populations [37] and rates of smoking remain high
among these populations [38].
With regard to alcohol, the dominance of supply
reduction interventions in Australia possibly reﬂects the
disproportionately high burden of alcohol harms in
remote Indigenous Australian communities [9], and
widespread political support for community-level alcohol
restrictions to reduce risky alcohol consumption and
related harms [39]. It might also reﬂect the relative ease
of implementing these strategies, compared with the
time, commitment and high levels of engagement
required to successfully implement more participatory
alcohol intervention approaches in Indigenous commu-
nities [40]. A recent review of Indigenous community
studies published between 1990 and 2015 has shown that
despite much rhetoric about the importance of commu-
nity development interventions designed, implemented
and evaluated in partnership with Indigenous communi-
ties, only 31 such evaluations were published in this
25 year period, and they were of low methodological
quality [41]. In clinical settings, it might similarly have
been expected that a greater number of studies reporting
the cost-effectiveness of alcohol interventions for
Indigenous peoples would have been published, consid-
ering the high strength of the evidence base for alcohol
brief interventions delivered in non-Indigenous clinical
settings [42] and their relatively low rates of delivery to
Indigenous Australians in primary health care [43].
Only 41% (n = 30) out of 73 intervention studies
employed an EPOC evaluation design. The dominance
of non-EPOC designs is consistent with ﬁndings of previ-
ous reviews of Indigenous health research, which found
that few study designs used to evaluate drug and alcohol
interventions speciﬁcally targeting Indigenous peoples
employ randomisation and a control group [44–47].
The RCT is the most rigorous study design, but its im-
plementation is not always feasible [48], particularly in
Indigenous communities [49]; only one third of EPOC
evaluation designs employed an RCT. Practical and
methodologically rigorous study design alternatives for
increasing the output of robust intervention studies in
the Indigenous drug and alcohol ﬁeld should therefore
be considered. Encouragingly, there is recent evidence
of researchers in the Indigenous drug and alcohol ﬁeld
implementing methodologically rigorous alternatives to
RCTs, such as the Multiple Baseline design (MBD)
[50–53]. Methodologically, this design staggers the im-
plementation of interventions across multiple sites with
each site acting as a comparative control for other sites
for the period before it receives the intervention [54].
Practically, theMBD ismore cost and time-efﬁcient than
RCTs and more feasible for evaluating public health,
policy and community-level interventions [55]. Despite
its methodological rigour and practical beneﬁts, no
intervention study in this review employed the MBD
and few employed similar alternatives. The process of
implementing methodologically rigorous alternatives,
and RCTs, as described by researchers currently utilising
them to evaluate Indigenous drug and/or alcohol
interventions, strongly suggests that partnerships
between researchers, Indigenous communities and
healthcare providers are required, to enable researchers’
methodological skills and expertise to be combined with
community members’ local knowledge and experience,
and healthcare providers’ expertise in designing and
implementing services and programs [50–53].
Limitations of methodology
Grey literature publications were not included as they
have not been subject to peer review. As well-designed
studies are likely to be published in peer-reviewed
journals [56], it seems unlikely that rigorous studies
would have been under-represented. There may be
disagreement over the classiﬁcation system used to cate-
gorise types of research output. The classiﬁcation system
has, however, been used in previous reviews of Indige-
nous health research [14], enabling comparison of
outputs of Indigenous drug and alcohol research with
Indigenous health researchmore broadly. It also provides
a useful indicator for those working in the Indigenous
drug and alcohol ﬁeld of the potential for outputs being
produced to inform policy and practice. Publications
may have been misclassiﬁed, although good agreement
(kappa = 0.62) between blinded coders suggests not.
Study design was the main indicator used to assess the
quality of intervention studies. Indicators related to im-
plementation of a study design (e.g. selection bias, con-
founding, attrition) were not examined. Study designs
may have been implemented in a way that compounded
weaknesses and compromised strengths inherent in their
design. Differences in inherent methodological strengths
and weaknesses across study designs (e.g. random vs.
non-random and single vs. two group designs) however,
make them an adequate indicator of the methodological
quality of an intervention evaluation [16].
Conclusion
While there has been an increase in the number and per-
centage of data-based publications in the Indigenous
drug and alcohol ﬁeld, the pattern of research output sug-
gests a dominance of descriptive research and a paucity of
intervention and measurement research, at least over the
past two decades. Compounding the lack of intervention
research has been the small number of interventions
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evaluated using methodologically rigorous study designs.
If mechanisms to increase the frequency and quality of
intervention research in the Indigenous drug and alcohol
ﬁeld are not implemented, evidence for informing Indig-
enous drug and alcohol policy and programs is likely to
be inconclusive or absent. Research institutions and
funding organisations should therefore consider the ﬁnd-
ings of this review when allocating research resources in
the Indigenous drug and alcohol ﬁeld. The overall
ﬁndings of this review suggest that greater priority should
be given to allocating research resources to studies with
the greatest potential to reduce Indigenous drug and
alcohol-related harms through the application of
evidence-based practice.
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